KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 154 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,655,000 | -55.6% | 311,600 | -44.6% | 0.27% | -72.2% |
| Q2 2016 | $3,726,000 | +51.2% | 562,900 | -19.6% | 0.97% | +208.0% |
| Q3 2015 | $2,464,000 | -15.8% | 700,000 | +204.3% | 0.31% | +3.0% |
| Q1 2015 | $2,928,000 | +3.5% | 230,000 | +15.0% | 0.30% | -36.7% |
| Q4 2014 | $2,830,000 | – | 200,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |